… -related mortality, with non-small-cell lung cancer (NSCLC) as … and GAS6 + stroma, suggesting
the potential of combining … into NK cell biology have increased in recent years, NK cell …

… that celecoxib increased the radiosensitivity of non-small cell … Therefore, this suggests that
combining celecoxib and sulindac … Erlotinib and celecoxib in treating patients with stage IIIB or …

… because in this period the maximum effect of radiotherapy occurs… trial, showed that diclofenac
combined with celecoxib and … are differences in tumor histology/biology or bone metastasis …

… the potential synergies of combining inhalation therapy with other … Similarly, another study
reported the creation of an erlotinib-… They can overcome biological barriers and increase …

… IND-Lip were found to have optimum physicochemical … Molecular biology kits were purchased
from other commercial … Several clinical trials have used this drug in combination with other …

… the involvement of TAMs in various biological processes. … clinical phase III or IV studies, either
alone or in combination … the toxicities depending on dose and maximum tolerated dosage. …

… in most non-small cell lung cancer patients, adding celecoxib to … A phase I study suggested
that only a high dose of celecoxib (… In the current study, we observed that the combination of …

… In advanced non-small cell lung cancer (NSCLC) patients … clinical trial of stage III colon
cancer, additional celecoxib to … Combined use of celecoxib and erlotinib (EGFR inhibitor) also …

… malignancies; and oral VNR for non–small cell lung cancer (NSCLC). With … High-dose
celecoxib and metronomic “Low-dose” … chemotherapy combined with bevacizumab and erlotinib in …

… on non-small cell lung cancer (NSCLC) and gastric cancer is … First is Cyclooxygenase-2(COX-2)
inhibitor Celecoxib. COX-… to assess the efficacy of fruquintinib in combination with other …